HALO is a research study looking at the survival rates of people diagnosed with Sickle Cell Disorder or Beta Thalassemia, acute Lymphoblastic or acute Myeloid Leukaemia in childhood and the long-term effects of that diagnosis and treatment.
Read more here: https://choralresearch.org.uk/sub-projects/haematology-lived-experience-and-outcomes-halo/